Overview

Edaravone Dexborneol for Treatment of Hypertensive Intracerebral Hemorrhage

Status:
Not yet recruiting
Trial end date:
2023-09-01
Target enrollment:
Participant gender:
Summary
pending
Phase:
Phase 2
Details
Lead Sponsor:
First Affiliated Hospital, Sun Yat-Sen University
Collaborator:
Jiangsu Simcere Pharmaceutical Co., Ltd.
Treatments:
Edaravone